article thumbnail

Microbial burden assessment of solid pharmaceutical products

European Pharmaceutical Review

The post Microbial burden assessment of solid pharmaceutical products appeared first on European Pharmaceutical Review. cepacia complex and E. coli in tablets and capsules with water activity lower than 0.60”.

article thumbnail

Pharmaceutical product positioning

eMediWrite

The process of giving a pharmaceutical product a unique identity on the market is called pharmaceutical product positioning. It entails recognising the special qualities and advantages of your product and conveying them to the intended market in a way that sets it apart from rival goods.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Benefits of a Sales Pilot for Pharmaceutical Products

MaBiCo

The Benefits of a Sales Pilot for Pharmaceutical Products A sales pilot is a short-term experiment that tests a product’s sales performance or a new sales approach. To say it in a few words, a sales pilot is a test to assess whether a pharmaceutical company should invest or not in the promotion of a product.

article thumbnail

Stakeholder Mapping for Pharmaceutical Products

Celeritas

Stakeholder Mapping involves identifying professionals in the target therapeutic field who would utilize or influence the utilization of the pharmaceutical product. Contacting stakeholders can be key to knowing where they stand upon the release of the pharmaceutical product. What is a Stakeholder Map?

article thumbnail

Ed Schoonveld Discusses List Prices for Pharmaceuticals in the US Compared to Other Countries

Pharmaceutical Commerce

In an interwith with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, Value and Access Advisor, Schoonveld Advisory, explains why pharmaceutical products tend to cost more in the US than the rest of the world.

article thumbnail

FDA lambasts Kilitch for unsanitary manufacturing conditions and issues warning letter to Natco, too

Fierce Pharma

It usually goes without saying that your pharmaceutical production workers need to be gowned and gloved while handling drug materials inside clean rooms. | In a four-observation warning letter issued this week, the U.S.

FDA 276
article thumbnail

TOP 10 CHALLENGES IN PHARMACEUTICAL PRODUCT LIFE CYCLE MANAGEMENT

eMediWrite

The following are the main obstacles to pharmaceutical product lifecycle management that I have attempted to highlight in this article: Internal and external complexity are rising. From product development to commercialization, quality must be integrated and managed as part of an efficient enterprise quality management system.